Pfizer's Document Bid Blocked In Celebrex Case

Law360, New York (March 25, 2008, 12:00 AM EDT) -- A federal magistrate judge has ruled against Pfizer Inc. in its battle to force the Journal of the American Medical Association to cough up an array of unpublished Celebrex and Bextra documents, as the pharmaceutical giant works to defend itself against thousands of product liability suits connected to the arthritis drugs.

On Monday, JAMA Editor Catherine D. DeAngelis clued the public into the drama that has been taking place behind the scenes of the Bextra and Celebrex multidistrict litigation that is currently unfolding in San Francisco...
To view the full article, register now.